J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on October 1, 2003

Papers In Press, published online ahead of print July 16, 2003
J. Lipid Res., doi:10.1194/jlr.M300129-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M300129-JLR200v1
44/10/1919    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kakafika, A. I.
Right arrow Articles by Tselepis, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kakafika, A. I.
Right arrow Articles by Tselepis, A. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on March 26, 2003
Revised on July 8, 2003
Accepted on July 14, 2003

The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity in normolipidemic and dyslipidemic populations

Anna I. Kakafika, Stavroula Xenofontos, Vasilis Tsimihodimos, Afroditi P. Tambaki, Evangelia S. Lourida, Rigas Kalaitzidis, Marios A. Cariolou, Moses Elisaf, and Alexandros D. Tselepis

Department of Chemistry, University of Ioannina, Ioannina 45110

Corresponding Author: atselep{at}cc.uoi.gr

Low plasma levels of high-density lipoprotein (HDL) represent an independent risk factor for coronary heart disease (CHD). Several lines of evidence suggest that the HDL-associated platelet-activating factor acetylhydrolase (HDL-PAF-AH) activity may substantially contribute to the antioxidant and anti-inflammatory effects of HDL, thus this activity may be an important component of the multiple mechanisms by which HDL slows the progression of atherosclerosis. Two enzymes associated with HDL express PAF-AH catalytic activity, PAF-AH itself and paraoxonase-1 (PON1). The relative contribution of these enzymes in the expression of PAF-AH activity on HDL remains to be established. In the present study we investigated whether the PON1 polymorphisms (M55L and Q192R) or the PAF-AH polymorphism V379A could affect the PAF-AH activity associated with HDL in both normolipidemic and dyslipidemic (Type IIA and IIB) populations. We show for the first time that among the polymorphisms studied, the PON1 M55L polymorphism significantly affects the HDL-PAF-AH activity in all studied groups, the PON1 L55L individuals having lower enzyme activity compared to those having 1 and 2 M alleles. No differences in the HDL content concerning the major apolipoprotein and lipid constituents were observed between individuals carrying the PON1 L55L and those with the M55M polymorphism. Our results provide evidence that PON1 significantly contributes to the pool of PAF-AH activity associated with HDL in human plasma, and suggest that the low PAF-AH activity in HDL carrying the PON1 L alloenzyme may be an important factor contributing to the low efficiency of this HDL to protect LDL against lipid peroxidation.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
D. N. Kiortsis, S. Tsouli, E. S. Lourida, V. Xydis, M. I. Argyropoulou, M. Elisaf, and A. D. Tselepis
Lack of Association Between Carotid Intima-Media Thickness and PAF-Acetylhydrolase Mass and Activity in Patients with Primary Hyperlipidemia
Angiology, July 1, 2005; 56(4): 451 - 458.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Rodriguez-Esparragon, J. C. Rodriguez-Perez, Y. Hernandez-Trujillo, A. Macias-Reyes, A. Medina, A. Caballero, and C. M. Ferrario
Allelic Variants of the Human Scavenger Receptor Class B Type 1 and Paraoxonase 1 on Coronary Heart Disease: Genotype-Phenotype Correlations
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 854 - 860.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Campo, M. A. Sardo, A. Bitto, A. Bonaiuto, G. Trimarchi, M. Bonaiuto, M. Castaldo, C. Saitta, S. Cristadoro, and A. Saitta
Platelet-Activating Factor Acetylhydrolase Is Not Associated with Carotid Intima-Media Thickness in Hypercholesterolemic Sicilian Individuals
Clin. Chem., November 1, 2004; 50(11): 2077 - 2082.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.